Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias
伊布替尼联合利妥昔单抗治疗对类固醇难治性或复发性自身免疫性血细胞减少症的慢性淋巴细胞白血病患者疗效显著。
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-023-01891-3
Nikitin, Eugene; Kislova, Maria; Morozov, Dmitry; Belyakova, Vera; Suvorova, Anna; Sveshnikova, Julia; Vyscub, Galina; Matveeva, Irina; Shirokova, Maria; Shipaeva, Anna; Klitochenko, Tatyana; Makarovskaya, Polina; Dmitrieva, Elena; Biderman, Bella; Sudarikov, Andrei; Obukhova, Tatyana; Samoilova, Olga; Kaplanov, Kamil; Konstantinova, Tatyana; Mayorova, Olga; Poddubnaya, Irina; Ptushkin, Vadim